Literature DB >> 1544865

Cancer mortality survey in a spa area (Misasa, Japan) with a high radon background.

M Mifune1, T Sobue, H Arimoto, Y Komoto, S Kondo, H Tanooka.   

Abstract

The 1952-88 cancer mortality records for inhabitants of the Misasa spa area, Japan, which has a high radon background, and a neighboring control area without any radon spa were analyzed (average outdoor Rn concentration: 26 mBq.liter-1 in Misasa vs. 11 mBq.liter-1 in the control area). Standardized mortality ratios (SMRs) for cancers of all sites were significantly lower among the inhabitants of both Misasa (male 0.538; female 0.463) and the control area (male 0.850; female 0.770), than in the whole Japanese population. Poisson regression analysis showed that the relative risks among the inhabitants of Misasa were significantly lower than in the control area for deaths from cancers of all sites (0.67) and stomach cancer (0.59). The relative risk of lung cancer death was also lower (0.55 times) in Misasa than in the control area, although the difference was not statistically significant. These results suggest that the linear no-threshold hypothesis for radiation risk may not be valid for exposure to low doses of radon.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1544865      PMCID: PMC5918656          DOI: 10.1111/j.1349-7006.1992.tb02342.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  3 in total

1.  Uncertainties about health effects of radon.

Authors:  P H Abelson
Journal:  Science       Date:  1990-10-19       Impact factor: 47.728

Review 2.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.

Authors:  N E Breslow; N E Day
Journal:  IARC Sci Publ       Date:  1987

3.  A test of the linear-no threshold theory of radiation carcinogenesis.

Authors:  B L Cohen
Journal:  Environ Res       Date:  1990-12       Impact factor: 6.498

  3 in total
  19 in total

1.  Association between Local External Gamma Rays and Frequency of Cancer in Babol-Iran.

Authors:  Ali Shabestani Monfared; Karimollah Hajian; Reza Hosseini; Akbar Nasir
Journal:  Dose Response       Date:  2010-01-15       Impact factor: 2.658

2.  Sparsely ionizing diagnostic and natural background radiations are likely preventing cancer and other genomic-instability-associated diseases.

Authors:  Bobby R Scott; Jennifer Di Palma
Journal:  Dose Response       Date:  2006-12-21       Impact factor: 2.658

3.  Smoking and hormesis as confounding factors in radiation pulmonary carcinogenesis.

Authors:  Charles L Sanders; Bobby R Scott
Journal:  Dose Response       Date:  2006-12-06       Impact factor: 2.658

4.  The bystander effect: recent developments and implications for understanding the dose response.

Authors:  R E J Mitchel
Journal:  Nonlinearity Biol Toxicol Med       Date:  2004-07

5.  Radiation hormesis: historical perspective and implications for low-dose cancer risk assessment.

Authors:  Alexander M Vaiserman
Journal:  Dose Response       Date:  2010-01-18       Impact factor: 2.658

Review 6.  Human exposure to high natural background radiation: what can it teach us about radiation risks?

Authors:  Jolyon H Hendry; Steven L Simon; Andrzej Wojcik; Mehdi Sohrabi; Werner Burkart; Elisabeth Cardis; Dominique Laurier; Margot Tirmarche; Isamu Hayata
Journal:  J Radiol Prot       Date:  2009-05-19       Impact factor: 1.394

7.  Lower cancer risk in medium high radon.

Authors:  E Tóth; I Lázár; D Selmeczi; G Marx
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

8.  The therapeutic use of radon: a biomedical treatment in Europe; an "alternative" remedy in the United States.

Authors:  Barbra E Erickson
Journal:  Dose Response       Date:  2006-09-23       Impact factor: 2.658

9.  Radon treatment controversy.

Authors:  Zygmunt Zdrojewicz; Jadwiga Jodi Strzelczyk
Journal:  Dose Response       Date:  2006-08-19       Impact factor: 2.658

10.  Radiation-stimulated epigenetic reprogramming of adaptive-response genes in the lung: an evolutionary gift for mounting adaptive protection against lung cancer.

Authors:  Bobby R Scott; Steven A Belinsky; Shuguang Leng; Yong Lin; Julie A Wilder; Leah A Damiani
Journal:  Dose Response       Date:  2009-06-11       Impact factor: 2.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.